TRIO-TECH (TRT) director exercises 70K options and sells 10K common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TRIO-TECH INTERNATIONAL director Jason T. Adelman reported option exercises and share sales. On June 23, 2026, he exercised derivative securities to acquire 70,000 shares of Common Stock at an exercise price of $3.11 per share, increasing his direct holdings.
Before that, he completed open-market sales of 5,000 shares at $15.84 per share on June 18, 2026 and 5,000 shares at $14.88 per share on June 19, 2026, for total sales of 10,000 shares. Following these transactions, he directly owns 210,094 shares of Common Stock, and the exercised derivative position is fully converted with no remaining derivative holdings reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10,000 shares ($153,600)
Net Sell
4 txns
Insider
ADELMAN JASON T
Role
null
Sold
10,000 shs ($154K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock (Right to Buy) | 70,000 | $0.00 | -- |
| Exercise | Common Stock | 70,000 | $3.11 | $218K |
| Sale | Common Stock | 5,000 | $14.88 | $74K |
| Sale | Common Stock | 5,000 | $15.84 | $79K |
Holdings After Transaction:
Common Stock (Right to Buy) — 0 shares (Direct, null);
Common Stock — 210,094 shares (Direct, null)
Footnotes (1)
Key Figures
Options exercised: 70,000 shares
Exercise price: $3.11 per share
Sale on June 18, 2026: 5,000 shares at $15.84
+5 more
8 metrics
Options exercised
70,000 shares
Common Stock acquired via derivative exercise on June 23, 2026
Exercise price
$3.11 per share
Price for exercising “Common Stock (Right to Buy)” derivative
Sale on June 18, 2026
5,000 shares at $15.84
Open-market sale of Common Stock
Sale on June 19, 2026
5,000 shares at $14.88
Open-market sale of Common Stock
Total shares sold
10,000 shares
Aggregate open-market sales on June 18–19, 2026
Shares owned after
210,094 shares
Direct Common Stock holdings following transactions
Derivative shares remaining
0 shares
Common Stock (Right to Buy) position after exercise
Option expiration date
March 25, 2030
Original expiration for exercised derivative grant
Key Terms
Form 4, open-market sale, derivative security, Common Stock (Right to Buy), +1 more
5 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock (Right to Buy) financial
"security_title": "Common Stock (Right to Buy)""
transaction_code "M" regulatory
"transaction_code": "M""
FAQ
What insider transactions did TRT director Jason T. Adelman report?
Jason T. Adelman reported exercising options for 70,000 TRT common shares and selling 10,000 shares. The exercise occurred on June 23, 2026, while the sales took place on June 18 and 19, 2026, in open-market transactions at prices above $14 per share.
What was the exercise price for Jason T. Adelman’s TRT stock options?
The derivative securities labeled “Common Stock (Right to Buy)” were exercised at $3.11 per share. Exercising these rights on June 23, 2026, converted them into 70,000 shares of TRT common stock and reduced the remaining derivative position under that grant to zero.
Did Jason T. Adelman retain any TRT derivative securities after the reported option exercise?
No, the filing shows that after exercising 70,000 “Common Stock (Right to Buy)” derivatives, the total derivative shares following the transaction are zero. This indicates the specific derivative position reported was fully exercised into common stock.